MODALITÉS TECHNIQUES DU TRAITEMENT LOCAL COMBINÉ

Références

1 Antoun S, Meshaka P, Soltani D, Blot F, Ducreux M, Lasser P, et al. Complications et tolérance de la chimio-hyperthermie intrapéritonéale (CHIP) après exérèse chirurgicale des carcinoses péritonéales (CP) : résultats d’une étude de phase I-II portant sur des CP de différentes origines. Bull Cancer 2000; 87 (9): 665-670.
2 Beaujard AC, Glehen O, Caillot J, Francois Y, Bienvenu J, Panteix G, et al..Intraperitoneal chemohyperthermia with Mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-2519
3 Elias D, Detroz B, Debaene B, Damia E, Leclercq B, Rougier P, et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: Reliable and unreliable concepts. Hepato-Gastroenterol 1994; 41: 207-213.
4 Elias D, Antoun S, Raynard B, Puizillout JM, Sabourin JC, Ducreux M et al. Traitement des carcinoses péritonéales par exérèse complète et chimiohyperthermie intrapéritonéale. Étude de phase I-II permettant de définir la meilleure procédure technique. Chirurgie 1999; 124: 380-389.
5 Elias D, Ouellet JF. Intraperitoneal chemohyperthermia. Rationale, technique, indications and results. Surg Oncol Clin North Am 2001; 10: 915-933.
6 Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76.
7 Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El Otmani A, et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis : pharmacokinetics and tissue distribution Ann Oncol 2002; 13: 267-272.
8 Elias D, Matsuhisa T, Sideris L, Liberale G, Drouard-Troalen L, Raynard B, Pocard M, Puizillou JM, Billard V, Bourget P, Ducreux M. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 2004; 15: 1558-65
9 Elias D, Benziri E, Di Pietrantonio D, Menegon P, Pocard M, Raynard B. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery : early 5-days normothermic chemotherapy versus intraoperative chemohyperthermia. Ann Surg Oncol 2007 ; 14 : 509-514
10 Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J of Surg 1994; 18: 150-155.
11 Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama, Osaki Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer research 1984; 44: 1840-1842.
12 Los G, Mutsaers PH, van der Vijgh WJ, Baldew GS, de Graaf PW, Mc Vie JG. Direct diffusion of cis-platinum in intraperitoneal rat tumors after intraperitoneal chemotherapy : a comparison with systemic chemotherapy. Cancer Res 1989; 48: 3380-3384.
13 Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruinn EA, Sclag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Sem Oncol 1989; 4 Supp 3: 83-97
14 Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
15 Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996; 20: 585-592.
16 Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 1998; 14: 254-261
17 Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6 (8): 790-796.
18 Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepato-Gastroenterology. 2001;48(42):1776-1782.
19 Zoetmulder FA. Cancer cell seeding during abdominal surgery: experimental studies. In: Peritoneal carcinomatosis: principles of management, P.H. Sugarbaker (ed.) Kluwer Acad Pubisher, Boston 1996; 155-162.

AMARAPE est une association loi 1901 créée par des patients atteints de deux maladies rares du péritoine : le pseudomyxome et le mésothéliome.

Connexion